State Street Healthcare ETFs XLV and XBI: Cost, Performance Comparison
Published on · Source: finance.yahoo.com
AI Summary
Summarized by AI from the source belowThe State Street Health Care Select Sector SPDR ETF (XLV) has an expense ratio of 0.08% and a dividend yield of 1.6%, with a recent share price of approximately $163.52. In contrast, the State Street SPDR S&P Biotech ETF (XBI) has an expense ratio of 0.35% and a dividend yield of 0.4%, priced around $151.46. XLV includes large-cap stocks such as Eli Lilly (NYSE:LLY) at 15.97% and Johnson & Johnson (NYSE:JNJ) at 10.67%. This comparison of cost and performance illustrates different investment strategies, affecting investor choices and asset allocations.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
About Johnson & Johnson (JNJ)
Johnson & Johnson is a healthcare giant spanning pharmaceuticals and medical devices, known for its deep drug pipeline.
The Health Care sector covers pharmaceutical, biotech, device and managed-care companies.
Earlier JNJ news
- Johnson & Johnson (JNJ) Offers 2% Yield, Projects 8.2% Earnings Growth
- XLV vs PBE: Comparing Two Healthcare ETFs for Investors
- Coca-Cola (KO) and Johnson & Johnson Big Premarket Moves
- Johnson & Johnson (JNJ) Settles Talc Lawsuits for $5.5 Billion
- Realty Income (O) Offers 5.11% Yield With 670 Consecutive Dividends
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
